Satish Singh
Satish Singh
Moderna Therapeutics
Verified email at
Cited by
Cited by
Antibody structure, instability, and formulation
W Wang, S Singh, DL Zeng, K King, S Nema
Journal of pharmaceutical sciences 96 (1), 1-26, 2007
Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications
SK Singh, MK Singh, PP Kulkarni, VK Sonkar, JJA Grácio, D Dash
ACS nano 6 (3), 2731-2740, 2012
Impact of product-related factors on immunogenicity of biotherapeutics
SK Singh
Journal of pharmaceutical sciences 100 (2), 354-387, 2011
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics
SK Singh, N Afonina, M Awwad, K Bechtold-Peters, JT Blue, D Chou, ...
Journal of pharmaceutical sciences 99 (8), 3302-3321, 2010
Controlled release: A quantitative treatment
L Fan, SK Singh
Springer Science & Business Media, 2012
Immunogenicity of protein aggregates—concerns and realities
W Wang, SK Singh, N Li, MR Toler, KR King, S Nema
International journal of pharmaceutics 431 (1-2), 1-11, 2012
Blockiotintelligence: A blockchain-enabled intelligent IoT architecture with artificial intelligence
SK Singh, S Rathore, JH Park
Future Generation Computer Systems 110, 721-743, 2020
Potential aggregation prone regions in biotherapeutics: a survey of commercial monoclonal antibodies
X Wang, TK Das, SK Singh, S Kumar
MAbs 1 (3), 254-267, 2009
Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange
A Zhang, SK Singh, MR Shirts, S Kumar, EJ Fernandez
Pharmaceutical research 29 (1), 236-250, 2012
Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of …
JG Barnard, S Singh, TW Randolph, JF Carpenter
Journal of pharmaceutical sciences 100 (2), 492-503, 2011
Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
T Kararli, R Bandyopadhyay, S Singh, L Hawley
US Patent App. 09/904,098, 2002
Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions
NJ Agrawal, S Kumar, X Wang, B Helk, SK Singh, BL Trout
Journal of pharmaceutical sciences 100 (12), 5081-5095, 2011
Hydrodynamic and thermodynamic aspects of the SDS-EHEC-water system
C Holmberg, S Nilsson, SK Singh, LO Sundeloef
The Journal of Physical Chemistry 96 (2), 871-876, 1992
Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation
P Kolhe, E Amend, S K. Singh
Biotechnology progress 26 (3), 727-733, 2010
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
Molecular basis of high viscosity in concentrated antibody solutions: strategies for high concentration drug product development
DS Tomar, S Kumar, SK Singh, S Goswami, L Li
MAbs 8 (2), 216-228, 2016
Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding
SK Singh, P Kolhe, AP Mehta, SC Chico, AL Lary, M Huang
Pharmaceutical research 28 (4), 873-885, 2011
Measuring arthropod biodiversity in the tropical forest canopy.
TL Erwin
Forest canopies., 109-127, 1995
Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties
L Li, S Kumar, PM Buck, C Burns, J Lavoie, SK Singh, NW Warne, ...
Pharmaceutical research 31 (11), 3161-3178, 2014
A review on the bioenergetics of anaerobic microbial metabolism close to the thermodynamic limits and its implications for digestion applications
L Leng, P Yang, S Singh, H Zhuang, L Xu, WH Chen, J Dolfing, D Li, ...
Bioresource technology 247, 1095-1106, 2018
The system can't perform the operation now. Try again later.
Articles 1–20